Shilfenib 200mg Tablet
Marketer
Shilpa Medicare Ltd
Salt Composition
Sorafenib (200mg)
Overview Shilfenib 200mg Tablet
Lenvatinib 200mg tablets are tyrosine kinase inhibitors prescribed for treating liver, kidney, and thyroid cancers. Administer this medication on an empty stomach, consistently at the same time daily for optimal efficacy. Dosage and frequency are determined by your physician, based on your specific condition and may vary. Strictly adhere to your doctor's instructions; improper use or overdose can lead to severe adverse effects. Therapeutic benefits may take weeks or months to manifest; discontinue only under your doctor's guidance. Common side effects include tiredness, nausea, appetite loss, hair thinning, and bowel changes. High blood pressure is a potential side effect, necessitating regular monitoring. Report severe skin reactions (rash), or hand/foot pain, swelling, and redness immediately. Prior to commencing treatment, inform your doctor of any existing heart, liver, kidney disease, or hypertension. Inform your healthcare provider of all other medications you are taking, as interactions are possible. This medication is contraindicated during pregnancy and breastfeeding; reliable contraception is crucial for both partners throughout treatment.
Uses of Shilfenib 200mg Tablet
Malignancies affecting the liver, kidneys, and thyroid gland.
Major Benefits of Shilfenib 200mg Tablet:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the 200mg Shilfenib tablet whole; avoid chewing, crushing, or fracturing it. Administration should be on an empty stomach.
Common Side effects of Shilfenib 200mg Tablet:
- Fatigue
- Nausea
- Loss of appetite
- Diarrhea
- Abdominal pain
- Hair loss
- Weight loss
- Rash
- Painful blisters on hands and feet
How to use Shilfenib 200mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Shilfenib 200mg Tablet on an empty stomach.
How Shilfenib 200mg Tablet works:
Oncaspar 200mg tablets are a cancer treatment that inhibits the activity of a faulty protein responsible for cancer cell proliferation, thus hindering or slowing tumor growth.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Shilfenib 200mg Tablet may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Use of Shilfenib 200mg Tablets is contraindicated during pregnancy due to confirmed risk to the fetus. In exceptional, life-threatening circumstances, a physician may prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingUNSAFE
The use of Shilfenib 200mg tablets while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingSAFE
Driving ability is typically unaffected by Shilfenib 200mg Tablets.
KidneySAFE IF PRESCRIBED
For individuals with kidney impairment, Shilfenib 200mg tablets are considered safe. Dosage modification for Shilfenib 200mg tablets isn't necessary. Routine blood work monitoring during treatment is advisable.
LiverCAUTION
Patients with severe hepatic impairment should use Shilfenib 200mg tablets cautiously. Dosage modification of Shilfenib 200mg tablets may be necessary. Physician consultation is advised.
What if you forget to take Shilfenib 200mg Tablet :
Omit any missed Shilfenib 200mg Tablet dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Shilfenib 200mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Diaryl Ether Derivatives |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Action Class | Kinase inhibitors targeting tyrosine |
3,018 People bought this recently